Harm Reduction Counseling for Cannabis Employ During Pregnancy and Lactation
As cannabis use becomes increasingly prevalent and socially accepted, particularly with expanding legalization efforts across many states, healthcare professionals are facing a growing need to address its potential impact on pregnancy and breastfeeding. Even as complete abstinence remains the recommended course of action, a nuanced approach incorporating harm reduction counseling is gaining traction as a pragmatic strategy to support pregnant and lactating individuals who continue to use cannabis. This approach acknowledges the complexities of substance use and aims to minimize potential adverse outcomes for both mother and child.
The American College of Obstetricians & Gynecologists (ACOG) has recognized the rising rates of cannabis use among pregnant and lactating individuals, ranging from 3.9% to 16.0% according to a 2025 clinical consensus report. Among young adults aged 19–22 years, usage is reported to be as high as 43% . This increase is fueled by factors such as increased accessibility, medical prescriptions, and a perception of safety, often fueled by misinformation. Obstetrician-gynecologists and other healthcare providers are now tasked with not only screening for cannabis use but also providing evidence-based counseling to reduce potential harm.
Understanding the Risks
Cannabis, encompassing products derived from Cannabis sativa, Cannabis indica, and Cannabis ruderalis, is currently the most commonly used illicit drug under U.S. Federal law . The primary concern stems from the fact that cannabis crosses the placenta, exposing the developing fetus to cannabinoids, and is also present in breast milk, impacting the nursing infant. Research, while often limited by retrospective study designs and self-reporting, suggests a potential link between cannabis use during pregnancy and adverse outcomes, including spontaneous preterm birth, low birth weight, and developmental delays .
The endocannabinoid system plays a crucial role in pregnancy implantation, placentation, and fetal neurologic development, making the fetus particularly vulnerable to the effects of cannabis exposure. While the scientific literature remains somewhat mixed, recent systematic reviews and meta-analyses have indicated an association between cannabis use – particularly heavy use – and adverse perinatal outcomes . Longitudinal cohort studies also suggest potential long-term neurobehavioral effects on children exposed to cannabis in utero. Potential risks include growth restriction, stillbirth, and neonatal intensive care unit admission .
The Shift Towards Harm Reduction
Traditionally, the approach to substance use during pregnancy has centered on complete abstinence. However, recognizing the challenges of achieving this goal, and acknowledging the potential for stigmatization that can deter individuals from seeking prenatal care, harm reduction strategies are gaining acceptance. Harm reduction doesn’t necessarily endorse cannabis use, but rather focuses on minimizing the potential negative consequences for both mother and baby when abstinence isn’t immediately achievable.
Harm reduction counseling involves an open and non-judgmental dialogue between the healthcare provider and the patient. It begins with honest assessment of the patient’s cannabis use – frequency, amount, method of consumption, and reasons for use. This assessment should be conducted in a sensitive manner, building trust and rapport. The goal is to understand the individual’s circumstances and motivations, rather than simply lecturing about the risks.
Key Components of Harm Reduction Counseling
Several key components are central to effective harm reduction counseling for cannabis use during pregnancy and lactation:
- Education: Providing accurate, evidence-based information about the potential risks of cannabis exposure to the fetus and infant. This includes explaining how cannabis affects the developing brain and body.
- Reducing Frequency and Amount: If complete cessation isn’t possible, counseling should focus on reducing the frequency and amount of cannabis used. This might involve setting realistic goals and developing strategies to achieve them.
- Method of Consumption: Counseling should address the method of consumption. Smoking cannabis carries additional risks due to exposure to combustion byproducts. Alternative methods, such as edibles, may be less harmful, although the delayed onset of effects can lead to accidental overconsumption.
- Avoiding Concurrent Substance Use: Counseling should emphasize the importance of avoiding the concurrent use of cannabis with other substances, such as alcohol or tobacco, which can exacerbate the risks.
- Mental Health Support: Addressing underlying mental health concerns, such as anxiety or depression, which may be contributing to cannabis use. Referral to mental health professionals may be necessary.
- Breastfeeding Considerations: For lactating individuals, counseling should address the fact that cannabinoids are present in breast milk and can affect the infant. Expressing and discarding breast milk after cannabis use may be considered, although the duration of cannabinoid presence in breast milk is not fully understood.
It’s important to note that harm reduction is not a one-size-fits-all approach. Counseling should be tailored to the individual patient’s needs and circumstances. Healthcare providers should be prepared to address the patient’s concerns and provide ongoing support.
Challenges and Future Directions
Despite the growing recognition of harm reduction as a valuable approach, several challenges remain. One significant hurdle is the lack of robust research on the effectiveness of different harm reduction strategies. More research is needed to determine which interventions are most effective in reducing cannabis-related harm during pregnancy and lactation.
Another challenge is the stigma associated with substance use, which can prevent individuals from seeking help. Healthcare providers need to create a safe and non-judgmental environment where patients feel comfortable disclosing their cannabis use. Ongoing education is needed to dispel myths and misconceptions about cannabis and its effects on pregnancy and lactation.
The Canadian Centre on Substance Use and Addiction (CCSA) has published resources aimed at clarifying the risks and providing guidance for healthcare professionals . These resources emphasize the importance of individualized counseling and a compassionate approach.
The Path Forward
Addressing cannabis use during pregnancy and lactation requires a multifaceted approach that combines evidence-based counseling, ongoing research, and a commitment to reducing stigma. Harm reduction strategies offer a pragmatic and compassionate way to support pregnant and lactating individuals, minimizing potential harm to both mother and child. As cannabis policies continue to evolve, healthcare professionals must remain informed and adapt their approaches to provide the best possible care.
The Committee on Clinical Consensus–Obstetrics at the American College of Obstetricians & Gynecologists will continue to monitor the evolving research landscape and update its clinical guidance accordingly. The next scheduled review of the clinical consensus report is anticipated in late 2027. Readers are encouraged to share their experiences and perspectives on this important topic in the comments below.